| Autor: |
Caron KT; Division of Laboratory Sciences, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA., Zhu W; Division of Laboratory Sciences, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA., Bernert JT; Division of Laboratory Sciences, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA., Wang L; Division of Laboratory Sciences, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA., Blount BC; Division of Laboratory Sciences, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA., Dortch K; Division of Laboratory Sciences, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA., Hunter RE; Division of Laboratory Sciences, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA., Harmon T; Division of Laboratory Sciences, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA., Akins JR; Division of Laboratory Sciences, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA., Tsai J; Office on Smoking and Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA., Homa DM; Office on Smoking and Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA., Pirkle JL; Division of Laboratory Sciences, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA., Sosnoff CS; Division of Laboratory Sciences, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA. |
| Abstrakt: |
The objective of this study was to examine long-term trends in serum cotinine (COT) concentrations, as a measure of secondhand smoke (SHS) exposure, in U.S. nonsmokers using data from the National Health and Nutrition Examination Surveys (NHANES) from 2003 to 2018. We analyzed NHANES serum COT results from 8 continuous NHANES 2 year cycles from 2003 to 2018 using a liquid chromatography−tandem mass spectrometry assay that has been maintained continuously at the Centers for Disease Control and Prevention (CDC) since 1992. Serum COT concentrations (based on the geometric means) among nonsmokers in the U.S. decreased by an average of 11.0% (95% confidence interval (CI) [8.8%, 13.1%]; p < 0.0001) every 2 year cycle. From 2003 to 2018, serum COT concentrations in U.S. nonsmokers declined by 55.0%, from 0.065 ng/mL in 2003−2004 to 0.029 ng/mL in 2017−2018 (p < 0.0001). Significant decreases in serum COT concentrations were observed in all demographic groups. While disparities between these groups seems to be shrinking over time, several previously observed disparities in SHS exposure remain in 2017−2018. Serum COT concentrations of the non-Hispanic Black population remained higher than those of non-Hispanic Whites and Mexican Americans (p < 0.0001). Additionally, serum COT concentrations were significantly higher for children aged 3−5 years than other age groups (p ≤ 0.0002), and men continued to have significantly higher serum COT concentrations than women (p = 0.0384). While there is no safe level of exposure to SHS, the decrease in serum COT concentrations in the U.S. population as well as across demographic groupings represents a positive public health outcome and supports the importance of comprehensive smoke-free laws and policies for workplaces, public places, homes, and vehicles to protect nonsmokers from SHS exposure. |
